BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mousavi S, Bereswill S, Heimesaat MM. Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis. Microorganisms 2020;8:E482. [PMID: 32231139 DOI: 10.3390/microorganisms8040482] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Finsterer J. Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates. IJMS 2022;23:14222. [DOI: 10.3390/ijms232214222] [Reference Citation Analysis]
2 Du K, Foote MS, Mousavi S, Buczkowski A, Schmidt S, Bereswill S, Heimesaat MM. Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice. Microorganisms 2022;10:1953. [PMID: 36296229 DOI: 10.3390/microorganisms10101953] [Reference Citation Analysis]
3 Heimesaat MM, Mousavi S, Bandick R, Bereswill S. Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam. Eur J Microbiol Immunol (Bp) 2022. [PMID: 36069779 DOI: 10.1556/1886.2022.00014] [Reference Citation Analysis]
4 Weerasooriya G, Mcwhorter AR, Khan S, Chousalkar KK, Parveen S. Effects of Sublethally Injured Campylobacter jejuni in Mice. Microbiol Spectr. [DOI: 10.1128/spectrum.00690-22] [Reference Citation Analysis]
5 Zeidler H, Hudson AP. Quo vadis reactive arthritis? Curr Opin Rheumatol 2022;34:218-24. [PMID: 35699331 DOI: 10.1097/BOR.0000000000000880] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kozak S, Derina D. Prevention of Contamination of Broiler Chicken Carcasses with Campylobacter During Water Cooling. Fundamental and Applied Scientific Research in the Development of Agriculture in the Far East (AFE-2021) 2022. [DOI: 10.1007/978-3-030-91405-9_122] [Reference Citation Analysis]
7 Li H, Liu S, Han J, Li S, Gao X, Wang M, Zhu J, Jin T. Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems. Front Immunol 2021;12:777606. [PMID: 34790205 DOI: 10.3389/fimmu.2021.777606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Tomioka N, Yoochatchaval W, Takemura Y, Matsuura N, Danshita T, Srisang P, Mungjomklang N, Syutsubo K. Detection of potentially pathogenic Arcobacter spp. in Bangkok canals and the Chao Phraya River. J Water Health 2021;19:657-70. [PMID: 34371501 DOI: 10.2166/wh.2021.239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gorain C, Khan A, Singh A, Mondal S, Mallick AI. Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model. Gut Pathog 2021;13:48. [PMID: 34330327 DOI: 10.1186/s13099-021-00444-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wymore Brand M, Sahin O, Hostetter JM, Trachsel J, Zhang Q, Wannemuehler MJ. Campylobacter jejuni persistently colonizes gnotobiotic altered Schaedler flora C3H/HeN mice and induces mild colitis. FEMS Microbiol Lett 2020;367:fnaa163. [PMID: 33098301 DOI: 10.1093/femsle/fnaa163] [Reference Citation Analysis]
11 Zeidler H, Hudson AP. Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep 2021;23:53. [PMID: 34196842 DOI: 10.1007/s11926-021-01018-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
12 Bereswill S, Mousavi S, Weschka D, Heimesaat MM. Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis. Microorganisms 2021;9:1424. [PMID: 34209438 DOI: 10.3390/microorganisms9071424] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Mousavi S, Weschka D, Bereswill S, Heimesaat MM. Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis. Pathogens 2021;10:818. [PMID: 34209990 DOI: 10.3390/pathogens10070818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Heimesaat MM, Weschka D, Mousavi S, Bereswill S. Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice. Int J Mol Sci 2021;22:6683. [PMID: 34206478 DOI: 10.3390/ijms22136683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Corcionivoschi N, Gundogdu O. Foodborne Pathogen Campylobacter. Microorganisms 2021;9:1241. [PMID: 34200984 DOI: 10.3390/microorganisms9061241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Heimesaat MM, Mousavi S, Weschka D, Bereswill S. Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis-Results from a Preclinical Placebo-Controlled Intervention Study. Microorganisms 2021;9:1140. [PMID: 34070612 DOI: 10.3390/microorganisms9061140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Weschka D, Mousavi S, Biesemeier N, Bereswill S, Heimesaat MM. Survey of Pathogen-Lowering and Immuno-Modulatory Effects Upon Treatment of Campylobacter coli-Infected Secondary Abiotic IL-10-/- Mice with the Probiotic Formulation Aviguard®. Microorganisms 2021;9:1127. [PMID: 34070972 DOI: 10.3390/microorganisms9061127] [Reference Citation Analysis]
18 Singh A, Khan A, Ghosh T, Mondal S, Mallick AI. Gut Microbe-Derived Outer Membrane Vesicles: A Potential Platform to Control Cecal Load of Campylobacter jejuni. ACS Infect Dis 2021;7:1186-99. [PMID: 33724795 DOI: 10.1021/acsinfecdis.0c00744] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Lobo de Sá FD, Heimesaat MM, Bereswill S, Nattramilarasu PK, Schulzke JD, Bücker R. Resveratrol Prevents Campylobacter jejuni-Induced Leaky gut by Restoring Occludin and Claudin-5 in the Paracellular Leak Pathway. Front Pharmacol 2021;12:640572. [PMID: 33935732 DOI: 10.3389/fphar.2021.640572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Bereswill S, Mousavi S, Weschka D, Buczkowski A, Schmidt S, Heimesaat MM. Peroral Clove Essential Oil Treatment Ameliorates Acute Campylobacteriosis-Results from a Preclinical Murine Intervention Study. Microorganisms 2021;9:735. [PMID: 33807493 DOI: 10.3390/microorganisms9040735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Li Z, Huang Z, Li X, Huang C, Shen J, Li S, Zhang L, Wong SH, Chan MTV, Wu WKK. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barré syndrome. Cell Prolif 2021;54:e13024. [PMID: 33751722 DOI: 10.1111/cpr.13024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
22 Xu HM, Huang HL, Zhou YL, Zhao HL, Xu J, Shou DW, Liu YD, Zhou YJ, Nie YQ. Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain. Gastroenterol Res Pract 2021;2021:6699268. [PMID: 33510784 DOI: 10.1155/2021/6699268] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 22.0] [Reference Citation Analysis]
23 Heimesaat MM, Mousavi S, Weschka D, Bereswill S. Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis. Microorganisms 2021;9:169. [PMID: 33466708 DOI: 10.3390/microorganisms9010169] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
24 Jing X, Korchagina AA, Shein SA, Muraoka WT, Koroleva E, Tumanov AV. IL-23 Contributes to Campylobacter jejuni-Induced Intestinal Pathology via Promoting IL-17 and IFNγ Responses by Innate Lymphoid Cells. Front Immunol 2020;11:579615. [PMID: 33488580 DOI: 10.3389/fimmu.2020.579615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mousavi S, Weschka D, Bereswill S, Heimesaat MM. Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10-/- Mice. Pathogens 2020;10:7. [PMID: 33374868 DOI: 10.3390/pathogens10010007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
26 Heimesaat MM, Mousavi S, Escher U, Lobo de Sá FD, Peh E, Schulzke JD, Kittler S, Bücker R, Bereswill S. Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study. Microorganisms 2020;8:E1858. [PMID: 33255723 DOI: 10.3390/microorganisms8121858] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
27 Singh A, Khan A, Ghosh T, Mondal S, Mallick AI. Naturally secreted bacterial outer membrane vesicles: potential platform for a vaccine against Campylobacter jejuni.. [DOI: 10.1101/2020.10.16.342261] [Reference Citation Analysis]
28 Heimesaat MM, Mousavi S, Kløve S, Genger C, Weschka D, Tamas A, Reglodi D, Bereswill S. Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute Campylobacter jejuni-induced Enterocolitis in Mice. Pathogens 2020;9:E805. [PMID: 33007819 DOI: 10.3390/pathogens9100805] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
29 Heimesaat MM, Genger C, Klove S, Weschka D, Mousavi S, Bereswill S. The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis. Pathogens 2020;9:E804. [PMID: 33003421 DOI: 10.3390/pathogens9100804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Heimesaat MM, Mousavi S, Kløve S, Genger C, Weschka D, Giladi E, Bereswill S, Gozes I. Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis. Microorganisms 2020;8:E802. [PMID: 32466564 DOI: 10.3390/microorganisms8060802] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
31 Kløve S, Genger C, Mousavi S, Weschka D, Bereswill S, Heimesaat MM. Toll-Like Receptor-4 Dependent Intestinal and Systemic Sequelae Following Peroral Campylobacter coli Infection of IL10 Deficient Mice Harboring a Human Gut Microbiota. Pathogens 2020;9:E386. [PMID: 32443576 DOI: 10.3390/pathogens9050386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]